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250 H. Hewitson et al. / Stem Cell Research 16 (2016) 249–251We generated KCL026 clinical grade hESC line following protocols,
established previously (Ilic et al., 2012; Stephenson et al., 2012). The ex-
pression of the pluripotencymarkerswas tested after freeze/thaw cycle.
Differentiation potential into three germ layers was veriﬁed in vitro.
Materials and methods
Consenting process
We distribute Patient Information Sheet (PIS) and consent form to
the in vitro fertilization (IVF) patients if they opted to donate to research
embryos that were stored for 5 or 10 years. They mail signed consent
back to us and that might be months after the PIS and consent were
mailed to them. If in the meantime new versions of PIS/consent are im-
plemented, we do not send these to the patients or ask them to re-sign;
thewhole process is donewith the version thatwas given them initially.
ND, not determined.Fig. 1. Genetic pedigree tree. The couple undergoing IVF and prenatal genetic diagnosis
had 7 embryos in this particular cycle. Two embryos carrying the mutation in the SMN1
gene were donated for research. We derived hESC line KCL026 from one of the affected
embryos. Af, affected; C, Carrier; N, normal.
Fig. 2. Expression of pluripotency markers. Pluripotency is conﬁrmed by immunostaining (Oct
ﬁbers, visualized with rhodamine-phalloidin (red), are present in both feeders and hES cell coThe PIS/consent documents (PGD-V.8) were created on Jul. 01, 2010.
HFEA Code of Practice that was in effect at the time of document crea-
tion: Edition 8 — R.2 (http://www.hfea.gov.uk/2999.html). The donor
couple signed the consent on Jan. 12, 2011. HFEA Code of Practice that
was in effect at the time of donor signature: Edition 8 — R.2. HFEA
Code of Practice Edition 8 — R.2 was in effect 07 Apr. 2010–Apr. 06,
2011.Embryo culture and micromanipulation
Embryo culture and laser-assisted dissection of inner cell mass
(ICM) were carried out as previously described in details (Ilic et al.,
2012; Stephenson et al., 2012). The cellular area containing the ICM
was then washed and transferred to plates containing mitotically
inactivated human neonatal foreskin ﬁbroblasts (HFF).Cell culture
ICMplated onmitotically inactivatedHFFwere cultured as described
(Ilic et al., 2012; Stephenson et al., 2012). TE cells were removed me-
chanically from outgrowth (Ilic et al., 2007; Ilic et al., 2010). hESC colo-
nies were expanded and cryopreserved at the third passage.Viability test
Strawswith the earliest frozen passage (p. 2–3) are thawed and new
colonies are counted three days later. These colonies are then expanded
up to passage 8, atwhich point cellswere part frozen and part subjected
to standard battery of tests (pluripotency markers, in vitro and in vivo
differentiation capability, genetics, sterility, mycoplasma).Pluripotency markers
Pluripotencywas assessed using two different techniques: enzymat-
ic activity assay [alkaline phosphatase (AP) assay] and immunostaining
as described (Ilic et al., 2012; Stephenson et al., 2012; Petrova et al.,
2014).4, Nanog, TRA-1-60, TRA-1-81) and alkaline phosphatase (AP) activity assay. Actin stress
lonies, whereas AP activity (green) is detected only in hES cells. Scale bar, 50 μm.
Fig. 3. Differentiation of three germ layers in vitro is conﬁrmed by detection of markers: smooth muscle actin (ACTA2, red) for mesoderm, β-III tubulin (TUBB3, red) for ectoderm andα-
fetoprotein (AFP, red) for endoderm. Nuclei are visualized with Hoechst 33342 (blue). Scale bar, 100 μm.
251H. Hewitson et al. / Stem Cell Research 16 (2016) 249–251Differentiation
Spontaneous differentiation into three germ layers was assessed
in vitro as described (Ilic et al., 2012; Stephenson et al., 2012; Petrova
et al., 2014).
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